Aimmune Therapeutics Inc (AIMT) Inventory Turnover Ratio, from second quarter 2020 to second quarter 2019, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Aimmune Therapeutics Inc   (NASDAQ: AIMT)
 

Aimmune Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Aimmune Therapeutics Inc inventory turnover ratio, the Aimmune Therapeutics Inc 's ability to sell and replace its inventory in the second quarter 2020, sequentially increased to 2.1 in the second quarter 2020, AIMT's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Aimmune Therapeutics Inc in Jun 30 2020 quarter, has decreased to 174 days, compare to 1460 days, in the Mar 31 2020 quarter.

Within Healthcare sector Aimmune Therapeutics Inc achieved the highest inventory turnover ratio. While inventory turnover ranking remained unchanged in the Second Quarter 2020 compared to previous quarter at no. .

AIMT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Aimmune Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AIMT Inventory Turnover Ratio (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter
Y / Y Inventory Growth - - - - -
Y / Y Cost of Sales Growth - - - - -
Inventory Turnover Ratio (TTM) 2.1 0.25 - - -
AIMT's Total Ranking # # # # #
Average inventory processing period 174 1447 - - -
Seq. Inventory Growth 38.52 % - - - -
Seq. Cost of Sales Growth 1787.16 % - - - -




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Inventory Turnover Ratio Statistics
High Average Low
0 0 0
 



AIMT Company Profile >> Back to AIMT Efficiency Comparisons >> Compare AIMT Inventory Turnover Ratio to its Competitors

Financial Statements
Aimmune Therapeutics Inc 's Inventories $ 6 Millions Visit AIMT's Balance sheet
Aimmune Therapeutics Inc 's Cost of Revenues TTM $ 5 Millions Visit AIMT's Income Statement
What are AIMT's Sales? Visit AIMT's Sales by Segment

Other Inventory Turnover Ratios
Aimmune Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AIMT's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AIMT's Competitors
Inventory Turnover Ratio for AIMT's Suppliers
Inventory Turnover Ratio for AIMT's Customers

You may also want to know
AIMT's Sales Growth Rates AIMT's Pe Price to earnings ratio AIMT's Receivables Turnover Ratio AIMT's Stock Quote
AIMT's Net Income Growth Rates AIMT's Ps Price to Sales ratio AIMT's Sales per Employee AIMT's Asset Turnover Ratio
AIMT's Net Margin AIMT's Pb Price to Book ratio AIMT's Financial Strength Ratios AIMT's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2020, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2020 Inventories at quarter ending Jun 30 2020
Akebia Therapeutics Inc   2.48 $ 278.739  Millions$ 112  Millions
Neogen Corporation  2.48 $ 221.891  Millions$ 89  Millions
Venus Concept Inc   2.44 $ 38.117  Millions$ 16  Millions
Atrion Corporation  2.44 $ 102.072  Millions$ 42  Millions
Icu Medical Inc  2.42 $ 794.589  Millions$ 329  Millions
Staar Surgical Co  2.39 $ 41.254  Millions$ 17  Millions
China Pharma Holdings Inc  2.38 $ 8.954  Millions$ 4  Millions
Teleflex Incorporated  2.38 $ 1,161.610  Millions$ 488  Millions
Thermogenesis Holdings Inc   2.37 $ 9.875  Millions$ 4  Millions
Co diagnostics Inc   2.37 $ 6.530  Millions$ 3  Millions
Conmed Corporation  2.36 $ 407.076  Millions$ 172  Millions
Intuitive Surgical Inc   2.35 $ 1,434.800  Millions$ 610  Millions
Akorn Inc  2.34 $ 406.699  Millions$ 174  Millions
Neurometrix Inc   2.33 $ 2.674  Millions$ 1  Millions
Merck and Co Inc   2.31 $ 13,718.000  Millions$ 5,934  Millions
Earth Science Tech Inc   2.31 $ 0.241  Millions$ 0  Millions
Medtronic Plc  2.31 $ 9,563.000  Millions$ 4,144  Millions
Angiodynamics Inc   2.28 $ 113.885  Millions$ 50  Millions
Ligand Pharmaceuticals Incorporated  2.26 $ 14.068  Millions$ 6  Millions
Myomo Inc   2.26 $ 1.228  Millions$ 1  Millions
Adaptive Biotechnologies Corporation  2.25 $ 21.807  Millions$ 10  Millions
Encision Inc   2.23 $ 3.372  Millions$ 2  Millions
Cutera Inc   2.22 $ 75.537  Millions$ 34  Millions
Talphera Inc   2.21 $ 6.647  Millions$ 3  Millions
Repligen Corp  2.19 $ 130.391  Millions$ 60  Millions
Nanostring Technologies Inc   2.18 $ 47.454  Millions$ 22  Millions
Lifeloc Technologies Inc   2.17 $ 4.729  Millions$ 2  Millions
Allarity Therapeutics Inc   2.17 $ 0.061  Millions$ 0  Millions
Therapeutic Solutions International Inc   2.14 $ 0.008  Millions$ 0  Millions
Inspiremd Inc   2.14 $ 2.737  Millions$ 1  Millions

Date modified: 2026-09-12T06:20:58+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.